Mexico

Medical Device Regulation in Mexico (COFEPRIS)

Registration, Classification, and Market Entry Requirements

Mexico is one of the largest medical device markets in Latin America and a strategic entry point for manufacturers expanding into the region. Its regulatory system combines risk-based classification with registration requirements and increasing use of reliance pathways on approvals from other jurisdictions.

Successful entry into Mexico requires understanding device classification, registration pathways, and the role of a local regulatory representative.

Regulatory Authority

Medical devices in Mexico are regulated by the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS). COFEPRIS is responsible for device classification, product registration and approval, import authorization, and post-market surveillance and enforcement.

Regulatory Framework

Mexico’s system is risk-based, registration-driven, and increasingly reliant on international approvals. Medical devices must be registered with COFEPRIS before they can be marketed in Mexico.

Device Classification System

Mexico uses a three-class device risk classification system. Classification determines the level of documentation and review required.

Class	Risk Level	Examples
Class I	Low	Basic, low-risk devices
Class II	Moderate	Diagnostic devices, infusion pumps
Class III	High	Implantable and life-supporting devices

Market Authorization (Sanitary Registration)

All medical devices (except certain low-risk exemptions) require Sanitary Registration (Registro Sanitario). Key elements of the registration include device description and intended use, risk classification, technical documentation, evidence of safety and performance, and labeling information.

Reliance and Equivalence Pathways

One of the most important aspects of Mexico’s system is that COFEPRIS may rely on approvals from other regulatory authorities. These recognized reference authorities may include the United States (FDA), Canada (Health Canada), the European Union (CE Marking), and other recognized jurisdictions.

Practical Impact

If your device is already approved in another major market, the approval process in Mexico can be significantly accelerated and potentially have fewer document requirements. This makes Mexico a strong secondary expansion market.

Role of the Mexican Registration Holder

Foreign manufacturers must work through a local Mexican entity known as a Mexican Registration Holder (MRH), also referred to as a local authorized representative.

MRH Responsibilities

The MRH holds the registration with COFEPRIS, submits applications, acts as liaison with the regulator, and maintains regulatory compliance.

Strategic Consideration

Because the MRH controls the registration, your MRH partner selection is critical and contractual clarity is essential.

Quality System Requirements

Mexico expects compliance with quality system standards aligned with ISO 13485 and good manufacturing practices.

MDSAP

Mexico is not an MDSAP participant. However, MDSAP certification can support global compliance and may indirectly support submissions through reliance pathways.

Labeling Requirements

Medical device labeling in Mexico must include Spanish-language labeling, device identification and intended use, manufacturer and registration holder information, and instructions for use (as applicable). The quality and regulatory consistency of translations are essential.

Post-Market Requirements

Manufacturers and registration holders must comply with requirements for adverse event reporting, complaint handling, recall procedures, and ongoing regulatory compliance. COFEPRIS actively monitors product safety and may take enforcement action when necessary.

Mexico vs Brazil (Quick Comparison)

Topic	Mexico (COFEPRIS)	Brazil (ANVISA)
Market Authorization	Sanitary Registration	Cadastro / Registro
Local Representative	MRH required	BRH required
Classification	Class I–III	Class I–IV
Language	Spanish	Portuguese
Reliance Pathways	Strong	Limited
Complexity	Moderate	High

Why Mexico Is a Strategic Market

Mexico offers a large and growing healthcare market, strong trade relationships with the U.S., an increasing use of reliance pathways, and faster access when prior approvals exist. Mexico is often a logical expansion market following U.S., Canada, or EU approval.

Conclusion

Mexico’s regulatory system offers a practical and increasingly efficient pathway for medical device market entry, particularly for manufacturers with existing approvals in other major jurisdictions. And understanding classification, registration requirements, and reliance pathways is essential for success.